Privacy Policy
Signals Blog

Contributors

Categories

Update from the Clinic: February

Welcome to your Update from the Clinic for the month of February. bluebird made its debut in the oncology market and treated its first patient with a chimeric antigen receptor (CAR) product targeting a novel antigen. Ziopharm enrolled its first patient in a study...

Right Turn: Coming at you from a beach down south

We don’t need no education We don’t need no thought control No dark sarcasm in the classroom Teachers leave them kids alone Hey! teachers! leave the kids alone! All in all it’s just another brick in the wall. All in all you’re just another...

Cell Therapy Deal Review: February

Welcome to your deal review for the month of February. Astellas tied-off its acquisition of Ocata while GSK and Adaptimmune expanded their collaboration to develop cell-based immunotherapies. AVROBIO, a new cell and gene company based in Boston, Mass, and Toronto,...